Research and Practice in Thrombosis and Haemostasis · 2019 · 23 citations · 17 references
MedicineHealth InformaticsOncologyClinical InformaticsEarly DetectionElectronic Health RecordsDeep Vein ThrombosisThromboembolic DiseaseThromboembolism PreventionThrombosisThrombosis PreventionVenous ThromboembolismCancer-associated Deep Vein ThrombosisDeep Vein Thrombosis AssessmentDeep Vein Thrombosis DetectionDeep Vein Thrombosis ProphylaxisThromboprophylaxis In Cancer PatientsVenous Thromboembolism AssessmentVenous Thromboembolism DetectionVenous Thromboembolism Diagnosis
BACKGROUND: Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and hospitalization in cancer patients. OBJECTIVES: To evaluate the feasibility of an electronic alert to identify and screen at-risk individuals and gather rates of early detection of deep vein thrombosis (DVT). PATIENTS/METHODS: An alert was built into the electronic medical record based on a validated risk tool (Khorana Score [KS]) and outcomes evaluated in an initial silent phase. The alert functioned in real time to warn physicians of high-risk patients (KS ≥ 3) and suggested lower extremity screening ultrasonography in a subsequent active phase. RESULTS: Of 194 consecutive patients identified as high risk in the silent phase, 14 (7.2%) developed subsequent DVT or pulmonary embolism (PE) over 90-day follow-up, with a median of 27 days. Mean 90-day emergency room (ER) visits, all-cause admissions, and length of stay (days) for patients with DVT were 1.2, 1.6, and 9.1 compared to 0.89, 0.93, and 5.1 for all patients, respectively. In the active phase, 197 consecutive alerts met inclusion criteria, and 40 patients (20.3%) received a screening ultrasound. Five (12.5%) had a DVT and were started on therapeutic anticoagulation. Of patients with alerts who had screening deferred, 13 (8.3%) were later diagnosed with DVT (median 50.5 days) and 7 (4.5%) with PE. CONCLUSION: An automated alert may have value in early detection of DVT in high-risk cancer patients leading to earlier intervention, and could potentially prevent VTE-related morbidity.
17
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana, Nicole M. Kuderer, Eva Culakova et al. · Blood · 2008 · 2.2K citations · Full text
Medicine, Hematology, Oncology +14
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
Jeanet W. Blom · JAMA · 2005 · 2K citations
Medicine, Genetics, Hematology +14
Gary H. Lyman, Kari Bohlke, Alok A. Khorana et al. · Journal of Clinical Oncology · 2015 · 1.4K citations · Full text
Medicine, Hematology, Surgery +17
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Clare Hooper, Isabel Laurence, John Harvey et al. · Respiration · 2013 · 1.2K citations · Full text
Prediction of venous thromboembolism in cancer patients
Cihan Ay, Daniela Dunkler, Christine Marosi et al. · Blood · 2010 · 773 citations · Full text
Medicine, Hematology, Oncology +12